Skip to main content
Terug
Watch Compare

CURIS INC

Datakwaliteit: 100%
CRIS
NASDAQ Manufacturing Chemicals
€ 0,55
▲ € 0,05 (9,08%)
Marktkapitalisatie: 20,39 M
Prijs
€ 0,51
Marktkapitalisatie
20,39 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue declined -2,96% annually over 5 years
Negative free cash flow of -27,20 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 10,47%

Groei

Revenue Growth (5Y)
-2,96%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)-13,43%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROIC-51,31%
Net Margin-80,29%
Op. Margin-60,50%

Veiligheid

Debt / Equity
N/A
Current Ratio0,70
Interest CoverageN/A

Waardering

PE (TTM|NTM)
-2,69 | -0,52
Onder sectorgemiddelde (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E -2,7 -1,5
P/B — 1,6
ROE % — -54,0
Net Margin % -80,3 -41,5
Rev Growth 5Y % -3,0 1,8
D/E — 0,3

Koersdoel Analisten

3 analisten
Buy
Huidig
€ 0,55
+2467.4%
Koersdoel
€ 14,00
€ 5,00
€ 17,00
€ 20,00
Vooruitzicht
Forward K/W -0,52
Forward WPA -€ 0,96
Omzet Sch. 16,18 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 0,96
-€ 1,84 – -€ 0,24
 16,18 M 3
FY2026 -€ 1,15
-€ 1,80 – -€ 0,29
 8,54 M 3

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,43 -€ 0,50 -15,0%
Q32025 -€ 0,60 -€ 0,49 +18,3%
Q22025 -€ 1,52 -€ 0,68 +55,1%
Q12025 -€ 1,26 -€ 1,25 +1,1%

All Fundamental Metrics
Growth
Revenue Growth (1Y) -13,43% Revenue Growth (3Y) -2,94%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -2,96% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 9,44 M Net Income (TTM) -7,58 M
ROE N/A ROA -26,66%
Gross Margin N/A Operating Margin -60,50%
Net Margin -80,29% Free Cash Flow (TTM) -27,20 M
ROIC -51,31% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,70
Interest Coverage N/A Asset Turnover 0,33
Working Capital -6,01 M Tangible Book Value -23,67 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,69 Forward P/E -0,52
P/B Ratio N/A P/S Ratio 2,16
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 1,26 Fwd Earnings Yield N/A
FCF Yield -133,41%
Market Cap 20,39 M Enterprise Value 11,34 M
Per Share
EPS (Diluted TTM) -0,58 Revenue / Share 0,24
FCF / Share -0,68 OCF / Share -0,68
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 358,76%
SBC-Adj. FCF -31,81 M Growth Momentum -10,47

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 9,44 M 10,91 M 10,02 M 10,16 M 10,65 M
Net Income -7,58 M -43,39 M -47,41 M -56,67 M -45,44 M
EPS (Diluted) -0,58 -6,88 -8,96 0,61 -0,50
Gross Profit — — — — —
Operating Income -5,71 M -44,54 M -48,33 M -53,02 M -42,07 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A 169.000,0 203.000,0 255.000,0 233.000,0 158.000,0
Interest Expense — — — — 0,0
Income Tax 0,0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 19,97 M 41,27 M 77,28 M 108,85 M 162,30 M
Total Liabilities 14,50 M 47,26 M 57,61 M 62,30 M 71,59 M
Shareholders' Equity 5,46 M -6,00 M 19,67 M 46,55 M 90,71 M
Total Debt — — — 900.000,0 900.000,0
Cash & Equivalents 5,06 M 20,00 M 26,68 M 19,66 M 40,01 M
Current Assets 6,92 M 26,39 M 60,91 M 92,12 M 122,38 M
Current Liabilities 14,08 M 19,03 M 13,52 M 10,01 M 13,44 M